Please Note:
This profile was automatically generated using 112 references found on the Internet. This information has not been verified. Learn more...
This profile was automatically generated using 112 references found on the Internet. This information has not been verified. Learn more...
View all 112 references Web References
-
1. Speakers
www.sachsforum.com/zurich04/zu - [Cached]Published on: 6/30/2008 Last Visited: 6/30/2008
Brian Hargreaves | Tim McCarthy | Dr. Chris Henderson | Joël Besse | Dr. rer. nat. Markus Metzger | Dr. Tilman Dumrese | Hoda Abou-Jamra | Morris Berrie | Dr. Jonathan D. Turner | Susan Flynn | Spiro Rombotis | Dimitri Dimitriou | Sandrine Cailleteau | Marc Perret | Dr. Peter Reinisch | Dr. Andreas Wicki | Seth Yakatan | Stan Yakatan | Dr. Andrew Barber | Adi Seffer | Anthony Warnock-Smith | Dr Christian Zschocke | Martin Friedman | Dennis Purcell | Hans van Swaay | Dr. Frank Grams | Jonathan Freeman | Antoine Papiernik | Marc Zahn | Dr. Alexandra Goll | Nick Lowcock | William van Eesteren
...
Joël Besse is a Senior Partner in the life sciences sector, and joined Atlas Venture in 1995.After serving as an auditor at Arthur Andersen and at Crédit Lyonnais in Paris, he began his career in venture capital in 1991 with SED Ventures, a firm specializing in international life sciences investments.
At Atlas Venture, he was a founding investor in Actelion Pharmaceuticals Ltd. (SWX:ATLN), where he currently sits on the board, and Novuspharma S.p.A. (acquired by Cell Therapeutics in 2003).In addition to his current board seats (see below) Joël has also served on the boards of Axovan A.G. (acquired by Actelion Pharmaceuticals in 2003), Entomed S.A., Immuno-Designed Molecules S.A., Neurotech S.A., Laboratoires Effik S.A. (listed on Euronext in 1999 and acquired by Italfarmaco and Liconsa in 2003) and Modex Thérapeutiques S.A. (now Isotis S.A., SWX:ISO).
Joël holds a Master of Science degree from the University of Toulouse and graduated from Ecole Nationale Supérieure de I'Aéronautique et de l'Espace. -
2. Arrow Therapeutics Board of Directors
www.arrowt.co.uk/about-board.h - [Cached]Published on: 6/28/2008 Last Visited: 6/28/2008
Joël Besse , Non Executive Director
Joël Besse is a Senior Partner in the life sciences sector and has worked with Atlas Venture since 1995.Previously, Joël served as an auditor at Arthur Andersen and at Crédit Lyonnais in Paris.He began his career in venture capital in 1991 with SED Ventures, a firm specializing in international life sciences investments.
In addition to Arrow, Joël serves on the Board of Newron Pharmaceuticals, Prestwick Pharmaceuticals, Shogoo Pharmaceuticals KK, Sporever, U3 Pharma and Xytis.Other key investments include Actelion Pharmaceuticals, Axovan, Novuspharma, Nitec Pharmaceuticals, Fibrex Medical and Modex.
Joël holds a Master of Science degree from the University of Toulouse and graduated from Ecole Nationale Supérieure de I'Aéronautique et de l'Espace. -
3. www.japanpartnering.com
www.japanpartnering.com/pub/pr - [Cached]Published on: 4/25/2008 Last Visited: 4/25/2008
Joël Besse, Partner, Atlas Venture
